• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素对重症患者肠道微生物群的影响。

Impact of antibiotics on the gut microbiota of critically ill patients.

作者信息

Iapichino Gaetano, Callegari Maria Luisa, Marzorati Silvia, Cigada Marco, Corbella Davide, Ferrari Susanna, Morelli Lorenzo

机构信息

Istituto di Anestesiologia e Rianimazione, Università degli Studi, Polo San Paolo, via Di Rudinì 8, I-20142 Milano, Italy.

Centro Ricerche Biotecnologiche, Università Cattolica del Sacro Cuore, Via Milano 24, 26100 Cremona, Italy.

出版信息

J Med Microbiol. 2008 Aug;57(Pt 8):1007-1014. doi: 10.1099/jmm.0.47387-0.

DOI:10.1099/jmm.0.47387-0
PMID:18628503
Abstract

We evaluated the relationship between the intestinal microbiota composition and clinical outcome in a group of 15 high-risk patients admitted for acute infection and/or surgical/accidental trauma who were treated with systemic antibiotics according to standard intensive care unit (ICU) protocols. There was a high mortality rate amongst these patients, each of whom had a considerable organ failure score at admission, respiratory assistance during the most of their ICU stay and a long length of stay. All of these individuals received sedation and enteral nutrition, and the majority also received insulin, vasoactive drugs and some stress-ulcer prophylaxis agents. The intestinal microbiota composition was assessed using denaturing gradient gel electrophoresis (DGGE), a molecular biology tool used to characterize bacterial ecosystems. As all of the patient subjects were in good health prior to their acute illness and admission to the ICU, the first faecal samples obtained from this group showed a DGGE banding pattern that was similar to that of healthy subjects. After 1 week of critical illness, coupled with intensive care treatment, including antibiotics, a very definite alteration in the overall microbiota composition was evident, as revealed by a reduction in the number of DGGE bands. Further pronounced changes to the DGGE banding profiles could be observed in patients remaining in the ICU for 2 weeks. Moreover, a dominant band, identified by sequencing as highly related to Enterococcus, was detected in the DGGE profile of some of our patient subjects. We also performed real-time PCR and obtained results that were in agreement with our qualitative evaluations using DGGE. The degree of organ failure and ICU mortality was significantly higher in patients for whom a high reduction in microbiota biodiversity was coupled with a massive presence of enterococci. A statistically significant link between these two ecological traits and the use of clindamycin was also found.

摘要

我们评估了15名因急性感染和/或手术/意外创伤入院的高危患者的肠道微生物群组成与临床结局之间的关系,这些患者按照标准重症监护病房(ICU)方案接受了全身抗生素治疗。这些患者的死亡率很高,每位患者入院时器官衰竭评分都相当高,在大部分ICU住院期间都需要呼吸支持,且住院时间很长。所有这些患者均接受了镇静和肠内营养,大多数还接受了胰岛素、血管活性药物和一些应激性溃疡预防药物。使用变性梯度凝胶电泳(DGGE)评估肠道微生物群组成,DGGE是一种用于表征细菌生态系统的分子生物学工具。由于所有患者在急性疾病和入住ICU之前身体健康,从该组患者获得的首批粪便样本显示出与健康受试者相似的DGGE条带模式。在危重病1周后,加上包括抗生素在内的重症监护治疗,总体微生物群组成出现了非常明显的变化,表现为DGGE条带数量减少。在ICU住院2周的患者中,可以观察到DGGE条带图谱有进一步明显的变化。此外,在我们部分患者的DGGE图谱中检测到一条优势条带,经测序鉴定与肠球菌高度相关。我们还进行了实时PCR,获得的结果与我们使用DGGE的定性评估结果一致。微生物群生物多样性大幅降低且肠球菌大量存在的患者,其器官衰竭程度和ICU死亡率显著更高。还发现这两个生态特征与克林霉素的使用之间存在统计学上的显著关联。

相似文献

1
Impact of antibiotics on the gut microbiota of critically ill patients.抗生素对重症患者肠道微生物群的影响。
J Med Microbiol. 2008 Aug;57(Pt 8):1007-1014. doi: 10.1099/jmm.0.47387-0.
2
Prolonged impact of a one-week course of clindamycin on Enterococcus spp. in human normal microbiota.一周疗程的克林霉素对人类正常微生物群中肠球菌属的长期影响。
Scand J Infect Dis. 2009;41(3):215-9. doi: 10.1080/00365540802651897.
3
Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.重症监护患者接受选择性消化道去污染与健康受试者的肠道微生物群和耐药组比较分析。
Microbiome. 2017 Aug 14;5(1):88. doi: 10.1186/s40168-017-0309-z.
4
Appropriate chicken sample size for identifying the composition of broiler intestinal microbiota affected by dietary antibiotics, using the polymerase chain reaction-denaturing gradient gel electrophoresis technique.
Poult Sci. 2007 Dec;86(12):2541-9. doi: 10.3382/ps.2007-00267.
5
Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis.危重症患者的肠道微生物群特征、脓毒症的潜在生物标志物和风险变量。
Gut Microbes. 2020 Nov 9;12(1):1707610. doi: 10.1080/19490976.2019.1707610. Epub 2020 Jan 10.
6
Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients.危重症患者肠道微生物多样性丧失和病原体主导的肠道微生物群。
Microb Genom. 2019 Sep;5(9). doi: 10.1099/mgen.0.000293. Epub 2019 Sep 11.
7
Dysbiosis Across Multiple Body Sites in Critically Ill Adult Surgical Patients.危重症成年外科患者多身体部位的微生物群失调
Shock. 2016 Dec;46(6):649-654. doi: 10.1097/SHK.0000000000000691.
8
Co-colonization by multidrug-resistant bacteria in two Greek intensive care units.希腊两个重症监护病房中多重耐药菌的共同定植情况
Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):1947-55. doi: 10.1007/s10096-015-2436-4. Epub 2015 Jul 15.
9
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.降钙素原指导在危重症患者中缩短抗生素治疗时间的疗效和安全性:一项随机、对照、开放标签试验。
Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2.
10
PCR DGGE and RT-PCR DGGE show diversity and short-term temporal stability in the Clostridium coccoides-Eubacterium rectale group in the human intestinal microbiota.聚合酶链反应-变性梯度凝胶电泳(PCR-DGGE)和逆转录聚合酶链反应-变性梯度凝胶电泳(RT-PCR-DGGE)显示,人肠道微生物群中球形梭菌-直肠真杆菌组具有多样性和短期时间稳定性。
FEMS Microbiol Ecol. 2006 Dec;58(3):517-28. doi: 10.1111/j.1574-6941.2006.00179.x.

引用本文的文献

1
Interaction between gut microbiota and anesthesia: mechanism exploration and translation challenges focusing on the gut-brain-liver axis.肠道微生物群与麻醉之间的相互作用:聚焦肠-脑-肝轴的机制探索与转化挑战
Front Cell Infect Microbiol. 2025 Sep 8;15:1626585. doi: 10.3389/fcimb.2025.1626585. eCollection 2025.
2
Assessing changes to the fecal microbiota in dogs undergoing elective orthopedic surgery: A preliminary investigation.评估择期骨科手术犬粪便微生物群的变化:一项初步调查。
PLoS One. 2025 Jun 2;20(6):e0325163. doi: 10.1371/journal.pone.0325163. eCollection 2025.
3
Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness.
危重病中肠道微生物失调的发病机制和治疗机会。
Gut Microbes. 2024 Jan-Dec;16(1):2351478. doi: 10.1080/19490976.2024.2351478. Epub 2024 May 23.
4
Safety, feasibility, and impact on the gut microbiome of kefir administration in critically ill adults.危重症成人中食用开菲尔对肠道微生物群的安全性、可行性和影响。
BMC Med. 2024 Feb 20;22(1):80. doi: 10.1186/s12916-024-03299-x.
5
Gut microbiome dynamics and associations with mortality in critically ill patients.危重症患者的肠道微生物群动态变化及其与死亡率的关联
Gut Pathog. 2023 Dec 19;15(1):66. doi: 10.1186/s13099-023-00567-8.
6
Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition.肠道微生物群与危重症患者:通过益生菌和免疫营养调节免疫。
Nutrients. 2023 Aug 13;15(16):3569. doi: 10.3390/nu15163569.
7
Rapid Bacterial Detection and Gram-Identification Using Bacterially Activated, Macrophage-Membrane-Coated Nanowired-Si Surfaces in a Microfluidic Device.利用微流控装置中细菌激活的、巨噬细胞膜包裹的纳米硅表面进行快速细菌检测和革兰氏鉴定。
Nano Lett. 2023 Sep 13;23(17):8326-8330. doi: 10.1021/acs.nanolett.3c02686. Epub 2023 Aug 23.
8
Microbiota Metabolism Failure as a Risk Factor for Postoperative Complications after Aortic Prosthetics.微生物群代谢功能衰竭作为主动脉修复术后并发症的一个风险因素。
Biomedicines. 2023 Apr 30;11(5):1335. doi: 10.3390/biomedicines11051335.
9
Lower gut dysbiosis and mortality in acute critical illness: a systematic review and meta-analysis.急性危重病中的下消化道微生物群失调与死亡率:一项系统评价和荟萃分析。
Intensive Care Med Exp. 2023 Feb 3;11(1):6. doi: 10.1186/s40635-022-00486-z.
10
Comparative analysis of gut microbiota in healthy and diarrheic yaks.健康牦牛和腹泻牦牛肠道微生物菌群的比较分析。
Microb Cell Fact. 2022 Jun 3;21(1):111. doi: 10.1186/s12934-022-01836-y.